↓ Skip to main content

Oncolytic viruses combined with immune checkpoint therapy for colorectal cancer is a promising treatment option

Overview of attention for article published in Frontiers in immunology, July 2022
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (67th percentile)
  • Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

twitter
7 X users

Citations

dimensions_citation
22 Dimensions

Readers on

mendeley
32 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Oncolytic viruses combined with immune checkpoint therapy for colorectal cancer is a promising treatment option
Published in
Frontiers in immunology, July 2022
DOI 10.3389/fimmu.2022.961796
Pubmed ID
Authors

Yi Ren, Jia-Meng Miao, Yuan-Yuan Wang, Zheng Fan, Xian-Bin Kong, Long Yang, Gong Cheng

X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 32 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 32 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 4 13%
Student > Bachelor 3 9%
Student > Master 2 6%
Student > Postgraduate 2 6%
Lecturer 1 3%
Other 2 6%
Unknown 18 56%
Readers by discipline Count As %
Medicine and Dentistry 4 13%
Biochemistry, Genetics and Molecular Biology 3 9%
Immunology and Microbiology 3 9%
Pharmacology, Toxicology and Pharmaceutical Science 1 3%
Design 1 3%
Other 0 0%
Unknown 20 63%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 August 2022.
All research outputs
#7,985,011
of 26,169,168 outputs
Outputs from Frontiers in immunology
#9,252
of 33,003 outputs
Outputs of similar age
#141,109
of 440,879 outputs
Outputs of similar age from Frontiers in immunology
#460
of 2,020 outputs
Altmetric has tracked 26,169,168 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 33,003 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.5. This one has gotten more attention than average, scoring higher than 71% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 440,879 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.
We're also able to compare this research output to 2,020 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.